FCMI
Foresite Capital Management IV Portfolio holdings
AUM
$124M
This Quarter Return
+9.11%
1 Year Return
-24.36%
3 Year Return
+1.86%
5 Year Return
+16.17%
10 Year Return
–
AUM
$124M
AUM Growth
+$124M
(+11%)
Cap. Flow
-$131M
Cap. Flow
% of AUM
-105.92%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
1
Increased
–
Reduced
2
Closed
–
Top Buys
| 1 |
Xenon Pharmaceuticals
XENE
|
$5.01M |
Top Sells
| 1 |
Lyell Immunopharma
LYEL
|
$134M |
| 2 |
Kura Oncology
KURA
|
$1.7M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Pharvaris
PHVS
$1.44B
| $77.6M | 62.7% |
4,410,581
| – | – |
|
|
MAZE
2
Maze Therapeutics, Inc. Common Stock
MAZE
$665M
| $25.9M | 20.93% |
2,111,919
| – | – |
|
|
3
Lyell Immunopharma
LYEL
$217M
| $7.08M | 5.72% |
800,399
-15,207,600
| -95% | -$134M |
|
|
4
Xenon Pharmaceuticals
XENE
$3B
| $5.01M | 4.05% |
+160,000
| New | +$5.01M |
|
|
5
Kura Oncology
KURA
$722M
| $4.71M | 3.81% |
816,882
-295,000
| -27% | -$1.7M |
|
6
Relay Therapeutics
RLAY
$702M
| $3.46M | 2.79% |
1,000,000
| – | – |
|